Logo image of PTLE

PTL LTD-A (PTLE) Stock Fundamental Analysis

NASDAQ:PTLE - VGG7377S1011 - Common Stock

0.1743 USD
+0 (+1.04%)
Last: 8/27/2025, 8:13:05 PM
0.1713 USD
0 (-1.72%)
After Hours: 8/27/2025, 8:13:05 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to PTLE. PTLE was compared to 208 industry peers in the Oil, Gas & Consumable Fuels industry. PTLE has a great financial health rating, but its profitability evaluates not so good. PTLE has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year PTLE has reported negative net income.
PTLE had a negative operating cash flow in the past year.
PTLE Yearly Net Income VS EBIT VS OCF VS FCFPTLE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 -2M -4M

1.2 Ratios

The Return On Assets of PTLE (-39.57%) is worse than 94.23% of its industry peers.
The Return On Equity of PTLE (-810.41%) is worse than 91.83% of its industry peers.
Industry RankSector Rank
ROA -39.57%
ROE -810.41%
ROIC N/A
ROA(3y)-9.01%
ROA(5y)N/A
ROE(3y)-215.52%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PTLE Yearly ROA, ROE, ROICPTLE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 -200 -400 -600 -800

1.3 Margins

PTLE has a worse Gross Margin (2.45%) than 77.88% of its industry peers.
PTLE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 2.45%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PTLE Yearly Profit, Operating, Gross MarginsPTLE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 2 -2 -4

More info and screens

7

2. Health

2.1 Basic Checks

PTLE has more shares outstanding than it did 1 year ago.
PTLE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
PTLE Yearly Shares OutstandingPTLE Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2M 4M 6M 8M 10M
PTLE Yearly Total Debt VS Total AssetsPTLE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

An Altman-Z score of 6.53 indicates that PTLE is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 6.53, PTLE belongs to the top of the industry, outperforming 91.83% of the companies in the same industry.
There is no outstanding debt for PTLE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 6.53
ROIC/WACCN/A
WACCN/A
PTLE Yearly LT Debt VS Equity VS FCFPTLE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 500K -500K 1M

2.3 Liquidity

PTLE has a Current Ratio of 1.05. This is a normal value and indicates that PTLE is financially healthy and should not expect problems in meeting its short term obligations.
PTLE's Current ratio of 1.05 is in line compared to the rest of the industry. PTLE outperforms 47.12% of its industry peers.
A Quick Ratio of 1.05 indicates that PTLE should not have too much problems paying its short term obligations.
PTLE has a Quick ratio of 1.05. This is comparable to the rest of the industry: PTLE outperforms 55.77% of its industry peers.
Industry RankSector Rank
Current Ratio 1.05
Quick Ratio 1.05
PTLE Yearly Current Assets VS Current LiabilitesPTLE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for PTLE have decreased strongly by -676.10% in the last year.
PTLE shows a decrease in Revenue. In the last year, the revenue decreased by -3.89%.
EPS 1Y (TTM)-676.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-676.1%
Revenue 1Y (TTM)-3.89%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-3.89%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PTLE Yearly Revenue VS EstimatesPTLE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

PTLE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PTLE Price Earnings VS Forward Price EarningsPTLE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PTLE Per share dataPTLE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

PTLE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PTL LTD-A

NASDAQ:PTLE (8/27/2025, 8:13:05 PM)

After market: 0.1713 0 (-1.72%)

0.1743

+0 (+1.04%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.53%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap6.53M
AnalystsN/A
Price TargetN/A
Short Float %3.87%
Short Ratio0.05
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.07
P/FCF N/A
P/OCF N/A
P/B 10.64
P/tB 10.64
EV/EBITDA N/A
EPS(TTM)-0.43
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS2.62
BVpS0.02
TBVpS0.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -39.57%
ROE -810.41%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 2.45%
FCFM N/A
ROA(3y)-9.01%
ROA(5y)N/A
ROE(3y)-215.52%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover7.8
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.05
Quick Ratio 1.05
Altman-Z 6.53
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-676.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-676.1%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.89%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-3.89%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-537.14%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-170.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-170.02%
OCF growth 3YN/A
OCF growth 5YN/A